Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Treated With Insulin”

491 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 491 results

Post-approval studies (Phase 4)Study completedNCT02219750
What this trial is testing

Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients

Who this might be right for
Diabetes
Mackay Memorial Hospital 181
Testing effectiveness (Phase 2)Study completedNCT02408705
What this trial is testing

Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects

Who this might be right for
Type 1 Diabetes Mellitus
Medical University of Graz 14
Not applicableStudy completedNCT00735501
What this trial is testing

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 314
Not applicableLooking for participantsNCT05795439
What this trial is testing

The CARING Study: Creating and Restoring Health Through Nutrition Guidance

Who this might be right for
Type2diabetesType 2 Diabetes Treated With Insulin
Physicians Committee for Responsible Medicine 700
Post-approval studies (Phase 4)Study completedNCT01487798
What this trial is testing

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 170
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Not applicableStudy completedNCT00696995
What this trial is testing

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 509
Post-approval studies (Phase 4)Study completedNCT00347100
What this trial is testing

Insulin Glargine in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 387
Testing effectiveness (Phase 2)Study completedNCT02060916
What this trial is testing

Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Treated With Insulin
Boston Therapeutics 24
Not applicableStudy completedNCT01702311
What this trial is testing

Point-of-Care Glucose Testing and Insulin Supplementation

Who this might be right for
Diabetes
Emory University 235
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Not applicableStudy completedNCT06111508
What this trial is testing

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Who this might be right for
Type 2 Diabetes
University of Virginia 30
Not applicableStudy completedNCT01565733
What this trial is testing

Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,223
Not applicableStudy completedNCT05004948
What this trial is testing

Exercise Intervention Combined With Metformin in the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Prince Sattam Bin Abdulaziz University 57
Post-approval studies (Phase 4)Study completedNCT00742976
What this trial is testing

Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients

Who this might be right for
Diabetes Type 2Weight Gain
Rigshospitalet, Denmark 24
Not applicableStudy completedNCT00697450
What this trial is testing

Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 206
Not applicableUnknownNCT03570138
What this trial is testing

Efficacy of Flash Glucose-Sensing Technology on the Occurrence of Cardiac Arrhythmias Associated With Hypoglycemia

Who this might be right for
Insulin Treated Type 2 Diabetes With High Risk of Hypoglycemia
Poitiers University Hospital 200
Very early researchActive Not RecruitingNCT06826547
What this trial is testing

Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory Consequences

Who this might be right for
Diabetes Mellitus, Type 2 Treated With InsulinFasting, IntermittentRamadan Fasting+1 more
University Tunis El Manar 100
Testing effectiveness (Phase 2)Study completedNCT01068860
What this trial is testing

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose Tolerance
Novartis 246
Early research (Phase 1)Study completedNCT00511472
What this trial is testing

An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 70
Next Page